Sucampo
develops and commercializes therapeutic compounds for the treatment of genetic disorders and orphan diseases... Read moreSucampo
develops and commercializes therapeutic compounds for the treatment of genetic disorders and orphan diseases... Read more
Chairman & CEO
Peter Greenleaf
News
Oct 18, 2018
BioPortfolio
Sucampo: Sucampo Pharmaceuticals Inc SCMP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27092018 Prices from USD $250
Aug 06, 2018
BioPortfolio
Sucampo: Sucampo Pharmaceuticals Inc SCMP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 25042018 Prices from USD $250
Feb 14, 2018
The Business Journals: St. Louis
Sucampo: Mallinckrodt wraps up $1.2 billion acquisition
Feb 13, 2018
The Business Journals
Sucampo: Sucampo Pharmaceuticals closes on its $1.2B sale to a U.K. company
Feb 05, 2018
The Business Journals
Sucampo: Shareholders sue Sucampo, claim proposed sale undervalues the company
Jan 25, 2018
4-traders
Sucampo: Monteverde & Associates PC : Files Class Action Lawsuit On Behalf Of Shareholders Of Sucampo Pharmaceuticals, Inc. In The District Of Maryland
Jan 21, 2018
Market Cheetah
Sucampo: Lifshitz & Miller LLP Announces Investigation of Advanced Micro Devices, Aflac Incorporated, DST Systems, Inc., Forum Merger Corporation, GoPro, Inc., Sucampo Pharmaceuticals, Inc. and ZAIS Group Holdings, Inc.
Jan 03, 2018
BioPortfolio
Sucampo: Mallinckrodt snaps up Sucampo for $1.2bn
Jan 02, 2018
Reuters
Sucampo: BRIEF-Sucampo Pharmaceuticals Received Notification From FDA That It Has Extended PDUFA Goal Date By 3 Months
Dec 28, 2017
The Business Journals: Washington, D.C.
Sucampo: Sucampo execs to get hefty bonuses tied to proposed sale
Sucampo Competitors
1
2
3
4
5
6
7
8
9
10